Latest News and Press Releases

Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Meeting

WallabyPhenox treats first U.S. patient in PIANO IDE trial using p48 & p64 MW HPC flow diverters for intracranial aneurysms.

NexZen Extracts launches THCa flower bundles with top strains, plus exclusive discounts, subscriptions, and loyalty rewards for added savings.

Lausanne, Switzerland and Copenhagen, Denmark, March 20, 2026 (GLOBE NEWSWIRE) -- REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD Biopharma executive with more than 35 years of leadership...

TUCSON, Ariz., March 20, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial...

Scientist Dario Crosetto challenges CERN to a ‘Known Dataset Test’ at the TBPET 2026 Conference to prove 3D-Flow can save >$12B and millions of lives

Hyderabad, March 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence’s latest report, the global DNA sequencing market is witnessing strong growth, driven by advancements in genomic...

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative...

TORONTO, March 20, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that St. Michael’s Hospital (SMH), part of Unity...

-- First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or...